Live Your Vision’s Amgen AMGN Stock Holding History

Live Your Vision’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-147	Closed	-$30K	–	252
2018 Q3	$30K	Sell	147 -3	-2%	-$591	0.01%	140
2018 Q2	$29K	Buy	+150	New	+$26.5K	0.01%	150

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Live Your Vision's AMGN Position: Q4 2018 in Review

Live Your Vision sold out of Amgen (AMGN) in Q4 2018, closing a stake of 147 shares — an estimated $30K sold.

Live Your Vision first reported a position in AMGN in Q2 2018 and held it in 2 quarters. The position peaked at $30K in Q3 2018. 1,891 funds tracked by Wall St. Rank hold AMGN as of Q4 2018.

Live Your Vision reported no remaining Amgen position as of Q4 2018 after selling out during the quarter.
Live Your Vision sold 147 Amgen shares in Q4 2018, an estimated $30K.
Live Your Vision first reported a position in Amgen in Q2 2018 and held it in 2 quarters.
Live Your Vision's Amgen position peaked at $30K in Q3 2018.
1,891 funds tracked by Wall St. Rank held Amgen as of Q4 2018.

Based on Live Your Vision's 13F filing for Q4 2018, filed 16 Jan 2019.